See the abstract submission processes for Poster/Oral Presentations, Poster Awards, Symposium Guidelines, and Media Embargo Policy below. All 2021 Congress submissions are closed.
The Pharmaceutical Pipeline submissions deadline was Wednesday, 20 January 2021.
Pharmaceutical Pipeline Submitters – Your application will be submitted under the “Pharmaceutical Pipeline” submission type. Pharmaceutical Pipeline submissions should include those with early clinical data (Phase 1 and 2) on compounds for which Phase 3 data had not been presented. The goal is to generate enthusiasm for the many novel compounds under exploration, most of which have not reached Phase 3. This is not to exclude presentations of clinical data on compounds currently in Phase 3 targeted to truly untested mechanisms, since such data would also be of great interest. Pharmaceutical Pipeline submissions should be structured as: Background, Methods, Results and Discussion. There is a limit of 3200 characters, not counting spaces, for the text of your abstract submission. No images, graphs, or tables will be accepted. Submissions by women and minorities are highly encouraged. Note: Pharmaceutical Pipeline abstracts will not be included in the online abstract publication.
Late-Breaking Poster submissions are closed. The deadline to submit was 24 February 2021. Notification of acceptance or otherwise will be emailed to the presenter in March 2021.
Late-Breaking Poster abstracts should be structured as: Background, Methods, Results, and Discussion. Include as much actual data as possible. There is a limit of 3200 characters, not counting spaces, for the text of your abstract submission. The presenter will be required to submit a COI disclosure statement at the time of the submission. Submissions by women and minorities are highly encouraged. Note: Late-Breaking Poster abstracts will not be included in the online abstract publication.
The deadline to submit a poster/oral presentation is 2 December 2020. Notification of acceptance or otherwise will be emailed to the presenter in early January 2021.
- Presentation abstracts should be structured as: Background, Methods, Results, and Discussion. Include as much actual data as possible.
- Oral Presentations will last 10 minutes with an additional 5 minutes for discussion.
- There is a limit of 3200 characters, not counting spaces, for the text of your abstract submission. No images, graphs, or tables will be accepted for publication.
- The presenter will be required to submit a COI disclosure statement at the time of the submission.
- Submissions by women and minorities are highly encouraged.
The deadline to submit a poster/oral presentation is 2 December 2020. Poster awards will be presented during the 2021 Congress.
- New Investigators (researchers under the age of 40) and be a SIRS Member.
- Posters submitted during the poster/oral presentation submission process must indicate they are eligible for the award to be considered by clicking the “poster awards” box during the submission in step 3.
- Research of the highest quality
- Novel Work
- Large enough numbers of subjects
- Likely to have a future impact
- Novel and creative research
- Research that is characterized by rigorous and innovative scientific methods
*The deadline to submit a symposium was 21 October 2020. Notification for acceptance or otherwise will be emailed to all participants in mid-November.
- A symposium is a moderately formal 2-hour session that includes a co-chair, 4 presenters and 1 discussant. The co-chair may also be a presenter.
- Symposium proposals must include both the overall panel proposal, as well as the individual presenter abstracts. The panel chair is responsible for submitting the overall summary and each presenter is responsible for submitting their own individual abstract. Symposia chairs will have the opportunity to review the individual abstracts and finalize the submission.
- Each of the 4 presentations lasts 30 minutes which allows for a 20-minute presentation and 10-minute discussion period.
- The amount of symposia submissions by an individual is unlimited, but an individual cannot be listed for more than two total roles (chair, co-chair, presenter, or discussant) between accepted symposia and oral presentations. If sessions are selected where a participant is included more than twice, the participant will need to find a suitable replacement to be approved by the program chairs.
- One discussant per symposium is required. The discussant cannot also be a presenter. This individual will lead the discussion with panelists and attendees the last thirty minutes of the symposium. NO formal presentation, slides, or other audiovisuals are allowed for discussants; this rule will be strictly enforced.
- Symposium sessions will be scheduled with the assumption that all speakers agree to be available on all days of the meeting.
- Symposium participants should be from various institutions (preferably from different countries) so the meeting attendees get the benefit of cross-institutional collaboration. Proposals that have participants from only one institution should include a justification as to why this is necessary for the proposal. The Chair may be asked to replace a speaker if the abstract submission includes two speakers from the same institution.
- There is a limit of 16,200 characters for the text of your abstract submission. This includes title (200 characters), the overall abstract (3,200 characters) and each speakers’ abstract (3,200 characters each), not counting spaces. No images will be accepted.
- At the time of submission, all presenters, including the chair must submit his/her disclosures. Submissions will not be reviewed without a completed disclosure.
Any press release issued by a presenter, the presenter’s employer, or any other outside person or entity about a presentation scheduled for the SIRS Annual Meeting must be embargoed until the time and date of the presentation and should be clear that it is not sanctioned by SIRS. This includes any detail of the abstract and the title.